Page last updated: 2024-08-23

taurolidine and cyclin d1

taurolidine has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fu, Z; Li, F; Qi, J; Qin, C; Ren, W	1

Other Studies

1 other study(ies) available for taurolidine and cyclin d1

Article	Year
Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer. Oncology reports, 2018, Volume: 40, Issue:6 Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; NADH, NADPH Oxidoreductases; Proto-Oncogene Proteins c-bcl-2; STAT3 Transcription Factor; Taurine; Thiadiazines; Time Factors; Up-Regulation	2018

Article

Year

Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer.

Oncology reports, 2018, Volume: 40, Issue:6

Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; NADH, NADPH Oxidoreductases; Proto-Oncogene Proteins c-bcl-2; STAT3 Transcription Factor; Taurine; Thiadiazines; Time Factors; Up-Regulation

2018